Cargando…
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
Osteonecrosis of the jaw (ONJ) is a rare but very serious disease that can affect both jaws. It is defined as exposed bone in the maxillofacial region that does not heal within 8 weeks after a health care provider identification. ONJ can occur spontaneously or can be due to drugs like bisphosphonate...
Autores principales: | Lorusso, L., Pieruzzi, L., Gabriele, M., Nisi, M., Viola, D., Molinaro, E., Bottici, V., Elisei, R., Agate, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572199/ https://www.ncbi.nlm.nih.gov/pubmed/34291429 http://dx.doi.org/10.1007/s40618-021-01634-0 |
Ejemplares similares
-
MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
por: Valerio, Laura, et al.
Publicado: (2020) -
Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
por: Petcu, Eugen B, et al.
Publicado: (2012) -
Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
por: Lorusso, L., et al.
Publicado: (2023) -
Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018) -
Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012)